Institut Català d'Oncologia (ICO) L'Hospitalet

Barcelona 08908

0 studies enrolling now · 2 studies all time

What they study most

Advanced Renal Cell Carcinoma, BRAF V600E-mutant Metastatic Colorectal Cancer, Metastatic Renal Cell Carcinoma

Studies at this site

• Encorafenib, Binimetinib and Cetuximab in Subjects With Previously Untreated BRAF-mutant ColoRectal Cancer — Completed
• CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma — Completed